Predict your next investment

Venture Capital
aperturevp.com

See what CB Insights has to offer

Investments

70

Portfolio Exits

23

Funds

5

About Aperture Venture Partners

Aperture Venture Partners is a venture capital group focused primarily on the healthcare and healthy living industries. Initial investment size ranges between $1 million and $5 million and they invest nationally.

Aperture Venture Partners Headquarter Location

645 Madison Avenue 20th Floor

New York, New York, 10022,

United States

212-758-7325

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Aperture Venture Partners News

Nalu Medical Snares $104M Equity Round

Feb 19, 2022

Back to HomeCARLSBAD, CA, Nalu Medical, a company focused on chronic neuropathic pain, has raised $104 million equity financing led by MVM Partners and Gilde Healthcare.Nalu Medical, a private company focused on innovative and minimally invasive solutions for chronic neuropathic pain, announced the completion of a $104 million equity financing.The round was led by new investors, MVM Partners and Gilde Healthcare.Also participating in this round were new investors Pura Vida Investments and Aperture Venture Partners, as well as existing investors, Advent Life Sciences, Decheng Capital, Endeavour Vision, and Longitude Capital. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page. Disclaimer: This story is auto-aggregated & summarized by a computer program and has not been created by StartupAround.

Aperture Venture Partners Investments

70 Investments

Aperture Venture Partners has made 70 investments. Their latest investment was in XII Medical as part of their Series A on May 5, 2022.

CBI Logo

Aperture Venture Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/5/2022

Series A

XII Medical

$30M

Yes

5

3/25/2022

Seed VC

Lillii RNB

$3M

Yes

2

2/18/2022

Series D

Nalu Medical

$104M

Yes

8

11/12/2021

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

8/30/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/5/2022

3/25/2022

2/18/2022

11/12/2021

8/30/2021

Round

Series A

Seed VC

Series D

Seed VC

Series B

Company

XII Medical

Lillii RNB

Nalu Medical

Subscribe to see more

Subscribe to see more

Amount

$30M

$3M

$104M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

5

2

8

10

10

Aperture Venture Partners Portfolio Exits

23 Portfolio Exits

Aperture Venture Partners has 23 portfolio exits. Their latest portfolio exit was Bardy Diagnostics on August 06, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/6/2021

Acquired

$99M

15

10/16/2020

IPO

$99M

Public

3

5/12/2020

Acquired

$99M

2

11/7/2019

Merger

Subscribe to see more

$99M

Subscribe to see more

10

6/18/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/6/2021

10/16/2020

5/12/2020

11/7/2019

6/18/2019

Exit

Acquired

IPO

Acquired

Merger

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

15

3

2

10

10

Aperture Venture Partners Fund History

5 Fund Histories

Aperture Venture Partners has 5 funds, including Aperture Venture Partners.

Closing Date

Fund

Fund Type

Status

Amount

Sources

7/20/2021

Aperture Venture Partners

$75M

1

12/31/2015

Aperture Venture Partners IV

Subscribe to see more

Subscribe to see more

10

12/31/2014

Aperture Venture Partners III

Subscribe to see more

Subscribe to see more

$99M

10

12/31/2011

Aperture Venture Partners II LP

Subscribe to see more

Subscribe to see more

10

Aperture Venture Partners V

Subscribe to see more

Subscribe to see more

10

Closing Date

7/20/2021

12/31/2015

12/31/2014

12/31/2011

Fund

Aperture Venture Partners

Aperture Venture Partners IV

Aperture Venture Partners III

Aperture Venture Partners II LP

Aperture Venture Partners V

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$75M

$99M

Sources

1

10

10

10

10

Aperture Venture Partners Team

4 Team Members

Aperture Venture Partners has 4 team members, including current Managing Partner, Anthony Natale.

Name

Work History

Title

Status

Matthew S Tierney

Credit Suisse First Boston

Founder

Current

Anthony Natale

Prism VentureWorks, MDS Capital, and Lumira

Managing Partner

Current

Paul E. Tierney

General Partner

Current

Thomas P. Cooper

Senior Partner

Current

Name

Matthew S Tierney

Anthony Natale

Paul E. Tierney

Thomas P. Cooper

Work History

Credit Suisse First Boston

Prism VentureWorks, MDS Capital, and Lumira

Title

Founder

Managing Partner

General Partner

Senior Partner

Status

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.